引導式測驗 · 中等 等級

AI 在肺癌篩檢 CT 測驗

測試 AI 結節支持、篩檢與診斷、FDA 預期用途、假陽性風險、放射科醫生審查和後續要求。

相關引導路徑AI 在肺癌篩檢 CT
問題 1 的 8

What output is expected from the FDA-authorized lung CT CAD tool described here?

預覽每個問題8 問題

當您參加測驗時,就會出現答案和解釋。

  1. What output is expected from the FDA-authorized lung CT CAD tool described here?
    • Decide who is eligible for screening
    • Replace follow-up imaging after a positive result
    • Highlight potential nodules for radiologist review
    • Diagnose lung cancer independently from the image
  2. How does screening CT differ from a diagnostic CT?
    • There is no difference in purpose
    • Screening is used for eligible people without symptoms; diagnostic imaging investigates a clinical concern
    • Screening is only performed after a nodule is confirmed
    • Diagnostic CT is always AI-read and screening is not
  3. What can a positive AI nodule mark mean?
    • A confirmed cancer diagnosis
    • Proof that the person must have surgery
    • Evidence that the nodule is malignant
    • A candidate finding for radiologist review that may lead to follow-up
  4. Why can an AI nodule tool produce false positives?
    • Normal structures or benign nodules may resemble the patterns it flags
    • The model reads the patient’s family history directly
    • The scanner automatically labels every nodule as cancer
    • Radiologists never compare prior images
  5. What should a radiologist do with a model-generated nodule mark?
    • Change the screening eligibility rules
    • Review it in the source CT with clinical context and prior images
    • Accept it automatically as a diagnosis
    • Ignore image quality and patient history
  6. Why validate AI performance on local scanners and populations?
    • Image protocols and patient populations can affect model performance
    • FDA authorization guarantees identical performance everywhere
    • Local validation changes the medical diagnosis
    • A different scanner cannot alter image quality
  7. Which screening harm should patients discuss with a clinician?
    • The guarantee that no cancer can be missed
    • An automatic treatment from the AI tool
    • The removal of all incidental findings
    • False positives and follow-up tests after an abnormal finding
  8. What does an AI result alone establish?
    • That cancer is present or absent with certainty
    • That follow-up is unnecessary
    • Only a software output that must be interpreted in the screening pathway
    • That the patient meets screening criteria